Symptom evaluation in reflux disease. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials

Naveen Sharma; C Donnellan; C Preston; Brendan Delaney; G Duckett; Paul Moayyedi

doi:10.1136/gut.2003.034371

Symptom evaluation in reflux disease. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials

Naveen Sharma, C Donnellan, C Preston, Brendan Delaney, G Duckett, Paul Moayyedi

Cancer and Genomic Sciences

Research output: Contribution to journal › Article

20 Citations (Scopus)

Abstract

Symptoms are an important outcome for measurement in clinical trials into gastro-oesophageal reflux disease, but the optimal approach to symptom assessment has not been formally evaluated. The authors conducted a systematic review to assess how reflux symptoms have been evaluated and how well these correlate with oesophagitis healing and relapse.

Original language	English
Pages (from-to)	iv58-iv65
Journal	Gut
Volume	53
DOIs	https://doi.org/10.1136/gut.2003.034371
Publication status	Published - 1 May 2004

Access to Document

10.1136/gut.2003.034371

Cite this

@article{082ac1ac5d624309a5377d8cb80ba7df,

title = "Symptom evaluation in reflux disease. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials",

abstract = "Symptoms are an important outcome for measurement in clinical trials into gastro-oesophageal reflux disease, but the optimal approach to symptom assessment has not been formally evaluated. The authors conducted a systematic review to assess how reflux symptoms have been evaluated and how well these correlate with oesophagitis healing and relapse.",

author = "Naveen Sharma and C Donnellan and C Preston and Brendan Delaney and G Duckett and Paul Moayyedi",

year = "2004",

month = may,

day = "1",

doi = "10.1136/gut.2003.034371",

language = "English",

volume = "53",

pages = "iv58--iv65",

journal = "Gut",

issn = "1468-3288",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Symptom evaluation in reflux disease. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials

AU - Sharma, Naveen

AU - Donnellan, C

AU - Preston, C

AU - Delaney, Brendan

AU - Duckett, G

AU - Moayyedi, Paul

PY - 2004/5/1

Y1 - 2004/5/1

N2 - Symptoms are an important outcome for measurement in clinical trials into gastro-oesophageal reflux disease, but the optimal approach to symptom assessment has not been formally evaluated. The authors conducted a systematic review to assess how reflux symptoms have been evaluated and how well these correlate with oesophagitis healing and relapse.

AB - Symptoms are an important outcome for measurement in clinical trials into gastro-oesophageal reflux disease, but the optimal approach to symptom assessment has not been formally evaluated. The authors conducted a systematic review to assess how reflux symptoms have been evaluated and how well these correlate with oesophagitis healing and relapse.

UR - http://www.scopus.com/inward/record.url?scp=2342467372&partnerID=8YFLogxK

U2 - 10.1136/gut.2003.034371

DO - 10.1136/gut.2003.034371

M3 - Article

C2 - 15082617

SN - 1468-3288

VL - 53

SP - iv58-iv65

JO - Gut

JF - Gut

ER -

Symptom evaluation in reflux disease. A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials

Abstract

Access to Document

Fingerprint

Cite this